Back to search

Article

Direct-acting antiviral agents in the treatment of chronic Hepatitis C – Real-life experience from clinical practices in Pakistan

2019-09-30

Abstract excerpt

<h4>Background: </h4> This study aims to evaluate the clinical effectiveness in terms of sustained virological response (SVR), predictors of SVR and safety of available second generation generic direct-acting antivirals in Pakistani chronic Hepatitis C patients. <h4>Methods:</h4> This is a retrospective study conducted in multiple centers of Pakistan from January 2015 to January 2019. The samples include patients...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
999d11f2-64af-5a29-84ae-4b60b4776ca5
DOI
10.21203/rs.2.15322/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Direct-acting antiviral agents in the treatment of chronic Hepatitis C – Real-life experience from clinical practices in PakistanDOI 10.21203/rs.2.15322/v1
Direct-acting antiviral agents in the treatment of chronic hepatitis C-Real-life experience from clinical practices in Pakistan.Semantic proximity
Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China.Semantic proximity
Direct-acting antiviral regimens in Egyptian patients with chronic hepatitis C virus infection: A real-world single-center experience.Semantic proximity
Experience with direct-acting antivirals in genotype 1-5 infected chronic hepatitis C patients in Turkey.Semantic proximity
Direct-acting antiviral agents in patients with hepatitis C genotype 1-4 infections in a tertiary hospital.Semantic proximity
Direct-Acting Antiviral Therapy in HCV Patients: A Retrospective Study of the Pre- and Post-Treatment Impact in Saudi ArabiaSemantic proximity
Direct-acting antiviral therapy in HCV patients: a retrospective study of the pre- and post-treatment impact in Saudi Arabia.Semantic proximity
Real-Life Experience of Hepatitis C Treatment with Direct-Acting Antivirals in Genotypes 2 and 3.Semantic proximity
Outcome of hepatitis C patients in a community with predominant genotype 3 with standard-of-care treatment before and after advent of direct-acting antivirals: A retrospective-cum-prospective study.Semantic proximity
Treatment of HCV infection with direct-acting antiviral agents. Real life experiences from the Euro-Asian region.Semantic proximity
Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL.Semantic proximity
Key points for the management of hepatitis C in the era of pan-genotypic direct-acting antiviral therapySemantic proximity
Select a neighboring publication to make it the new centre.